Robert Weisman

Weisman covers the healthcare and life sciences industries for the Business section. He was a business reporter and editor for the Hartford Courant and the Seattle Times before joining the Globe in 2000.

Latest stories

Dana-Farber asks court for joint inventor status patents

By , Globe Staff

The institute asked a federal court to name one of its scientists co-inventor on a series of cancer immunotherapy patents granted to a Japanese drug maker.

Price caps on drugs would quash innovation, Vertex CEO says

By , Globe Staff

Industry leaders warned that government efforts to rein in prescription drug prices could stymie the development of innovative medicines.

Local firm wins key fight in high-stakes gene patent battle

By , Globe Staff

Cambridge’s Alnylam and a roster of academic institutions stand to profit from what could become one of the most significant drug innovations in a generation.

Verastem shares plunge as drug trial fails

By , Globe Staff

Shares of the Cambridge biotech dropped 70 percent after it reported that its lead drug candidate failed to help patients suffering from a rare lung cancer.